Healthcare Realty Trust (NYSE:HR) Releases Quarterly Earnings Results, Misses Estimates By $0.46 EPS

Healthcare Realty Trust (NYSE:HR) announced its quarterly earnings results on Thursday. The real estate investment trust reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.46), FiscalAI reports. The company had revenue of $286.64 million during the quarter, compared to the consensus estimate of $275.27 million. Healthcare Realty Trust had a negative net margin of 7.59% and a negative return on equity of 1.91%. The business’s revenue was down 3.4% compared to the same quarter last year. During the same period last year, the company earned $0.41 earnings per share.

Healthcare Realty Trust Stock Performance

Shares of HR stock opened at $19.08 on Tuesday. The company has a market cap of $6.54 billion, a PE ratio of -136.26 and a beta of 0.97. The stock’s fifty day moving average price is $18.17 and its two-hundred day moving average price is $18.82. Healthcare Realty Trust has a fifty-two week low of $16.31 and a fifty-two week high of $22.04.

Healthcare Realty Trust Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 20th. Investors of record on Tuesday, November 10th will be given a dividend of $0.24 per share. The ex-dividend date of this dividend is Tuesday, November 10th. This represents a $0.96 annualized dividend and a yield of 5.0%. Healthcare Realty Trust’s dividend payout ratio is currently -685.71%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on HR shares. JPMorgan Chase & Co. increased their target price on shares of Healthcare Realty Trust from $19.00 to $21.00 and gave the stock a “neutral” rating in a report on Thursday, July 9th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Healthcare Realty Trust in a research note on Wednesday, October 28th. Cantor Fitzgerald increased their target price on Healthcare Realty Trust from $22.00 to $24.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Wells Fargo & Company dropped their price target on Healthcare Realty Trust from $20.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Finally, UBS Group cut their price target on Healthcare Realty Trust from $21.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, October 13th. Five equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Healthcare Realty Trust currently has a consensus rating of “Hold” and an average target price of $21.36.

Insider Buying and Selling at Healthcare Realty Trust

In related news, COO Robert Hull sold 21,000 shares of Healthcare Realty Trust stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $19.11, for a total transaction of $401,310.00. Following the completion of the transaction, the chief operating officer owned 276,338 shares of the company’s stock, valued at $5,280,819.18. This trade represents a 7.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.56% of the stock is currently owned by corporate insiders.

About Healthcare Realty Trust

Healthcare Realty Trust Incorporated (NYSE: HR) is a real estate investment trust focused on owning, managing, acquiring and developing outpatient healthcare properties. Its portfolio primarily includes medical office buildings, ambulatory surgery centers, outpatient facilities and other properties used by healthcare providers.

The company leases space to health systems, physician groups and other healthcare organizations, with properties generally located on or near hospital campuses and in growing outpatient care settings.